Firefly Neuroscience is trading at $1.01, down 6.05%, after no clear company-specific catalyst was identified for August 21, 2026.

  • Recent disclosures included second-quarter results filed August 11 and shareholder-approved plan changes; neither directly explains today’s decline.
  • Broader markets are higher pre-market, making a market-wide explanation less compelling.
  • Catalyst remains unclear; monitor for delayed filings or announcements.